Cynthia Seidel-Dugan is Chief Scientific Officer of Werewolf Therapeutics Inc.
Person profile
Roles
Werewolf Therapeutics
Chief Scientific Officer
Address
Cambridge, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Jan 24 | HOWL Werewolf Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 4.64 | 150,000 | 696.00 k | 150,000 |
3 Jan 23 | HOWL Werewolf Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.05 | 115,900 | 237.59 k | 115,900 |